Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity.
Source:http://linkedlifedata.com/resource/pubmed/id/9468208
Circulation
1998
Feb
3
97
4
350-5
